Zaniolo, Orietta, Francesco Bamfi, and Sergio Iannazzo. 2007. “Budget Impact of Rosiglitazone in Type 2 Diabetes”. Farmeconomia. Health Economics and Therapeutic Pathways 8 (1):15-26. https://doi.org/10.7175/fe.v8i1.252.